| Lymphopenia during the COVID-19 infection: What it shows and what can be learned S Tavakolpour, T Rakhshandehroo, EX Wei, M Rashidian Immunology letters 225, 31, 2020 | 396 | 2020 |
| Linking tumor mutations to drug responses via a quantitative chemical–genetic interaction map MM Martins, AY Zhou, A Corella, D Horiuchi, C Yau, T Rakhshandehroo, ... Cancer discovery 5 (2), 154-167, 2015 | 65 | 2015 |
| Regulation of ceramide synthase by casein kinase 2-dependent phosphorylation in Saccharomyces cerevisiae T Fresques, B Niles, S Aronova, H Mogri, T Rakhshandehroo, T Powers Journal of Biological Chemistry 290 (3), 1395-1403, 2015 | 38 | 2015 |
| Noninvasive imaging of cancer immunotherapy O Abousaway, T Rakhshandehroo, AD Van den Abbeele, MF Kircher, ... Nanotheranostics 5 (1), 90, 2021 | 27 | 2021 |
| Pancreatic cancer cells upregulate LPAR4 in response to isolation stress to promote an ECM-enriched niche and support tumour initiation C Wu, T Rakhshandehroo, HI Wettersten, A Campos, T Von Schalscha, ... Nature cell biology 25 (2), 309-322, 2023 | 20 | 2023 |
| Cutaneous T-cell lymphoma PDX drug screening platform identifies cooperation between inhibitions of PI3Kα/δ and HDAC CH Wu, CY Yang, L Wang, HX Gao, T Rakhshandehroo, S Afghani, ... Journal of Investigative Dermatology 141 (2), 364-373, 2021 | 19 | 2021 |
| Molecular immune targeted imaging of tumor microenvironment T Rakhshandehroo, BR Smith, HJ Glockner, M Rashidian, ... Nanotheranostics 6 (3), 286, 2022 | 17 | 2022 |
| Direct N-or C-Terminal Protein Labeling Via a Sortase-Mediated Swapping Approach M Cong, S Tavakolpour, L Berland, H Glockner, B Andreiuk, ... Bioconjugate chemistry 32 (11), 2397-2406, 2021 | 7 | 2021 |
| A CAR enhancer increases the activity and persistence of CAR T cells T Rakhshandehroo, SR Mantri, H Moravej, BBV Louis, A Salehi Farid, ... Nature Biotechnology, 1-12, 2024 | 1 | 2024 |
| Development of an antigen-based approach to noninvasively image CAR T cells in real time and as a predictive tool J Fröse, J Rowley, AS Farid, T Rakhshandehroo, P Leclerc, H Mak, ... Science Advances 10 (38), eadn3816, 2024 | | 2024 |
| Development of a Stable Peptide–Major Histocompatibility Complex (MHC) via Sortase and Click Chemistry SC Uslu, UJ Lee, S Tavakolpour, O Abousaway, A Nili, L Bass, P Purwar, ... ACS Pharmacology & Translational Science, 2024 | | 2024 |
| Pancreatic cancer cells upregulate LPAR4 in response to isolation stress to create a fibronectin-rich extracellular matrix niche and promote tumor initiation C Wu, T Rakhshandehroo, HI Wettersten, A Campos, T Von Schalscha, ... Cancer Research 84 (6_Supplement), 2979-2979, 2024 | | 2024 |
| Cutaneous T-Cell Lymphoma PDX Drug Screening Platform Identifies Cooperation between Inhibitions of PI3Ka/d and HDAC CH Wu, CY Yang, L Wang, HX Gao, T Rakhshandehroo, S Afghani, ... | | 2020 |
| The combined role of stress and lysophosphatidic acid in pancreatic ductal adenocarcinoma progression T Rakhshandehroo UC San Diego, 2019 | | 2019 |
| Linking Tumor Mutations to Drug Responses via a Quantitative Chemical-Genetic Interaction Map (vol 5, pg 154, 2015) MM Martins, AY Zhou, A Corella, D Horiuchi, C Yau, T Rakhshandehroo Cancer Discovery 8 (8), 1045-1045, 2018 | | 2018 |
| Abstract LB-049: Cancer stem cell-produced lysophosphatidic acid reprograms surrounding tumor cells to a stem-like state T Rakhshandehroo, J Tan, B Grosshart, D Cheresh Cancer Research 78 (13_Supplement), LB-049-LB-049, 2018 | | 2018 |
| Tara Fresques1, 2, 3, Brad Niles1, 2, Sofia Aronova1, 4, Huzefa Mogri1 T Rakhshandehroo, T Powers | | 2014 |
